Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
1.
14 p, 762.0 KB Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis : Results from ASCLEPIOS I and II / Gärtner, Jutta (University Medical Centre Göttingen) ; Hauser, Stephen L. (University of California, San Francisco) ; Bar-Or, Amit (University of Pennsylvania) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cohen, Jeffrey A. (Cleveland Clinic Foundation) ; Cross, Anne H. (Washington University School of Medicine) ; Deiva, Kumaran (University Hospitals Paris Saclay) ; Ganjgahi, Habib (University of Oxford) ; Häring, Dieter A. (Novartis) ; Li, Bingbing (Novartis) ; Pingili, Ratnakar (Novartis) ; Ramanathan, Krishnan (Novartis) ; Su, Wendy (Novartis) ; Willi, Roman (Novartis) ; Kieseier, Bernd (Novartis) ; Kappos, Ludwig (University of Basel) ; Universitat Autònoma de Barcelona
Background: In the phase III ASCLEPIOS I and II trials, participants with relapsing multiple sclerosis receiving ofatumumab had significantly better clinical and magnetic resonance imaging (MRI) outcomes than those receiving teriflunomide. [...]
2022 - 10.1177/13524585221078825
Multiple sclerosis, Vol. 28 Núm. 10 (2022) , p. 1562-1575  
2.
18 p, 436.4 KB COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab / Cross, Anne H. (Department of Neurology. Washington University) ; Delgado, Silvia (University of Miami Miller School of Medicine) ; Habek, Mario (University Hospital Center Zagreb. University of Zagreb. School of Medicine) ; Davydovskaya, Maria (Moscow State Public Healthcare InsCity Clinical Hospital 24) ; Ward, Brian J. (Infectious Diseases Division. Research Institute of the McGill University Health Centre) ; Cree, Bruce A. C (UCSF Weill Institute for Neurosciences. Department of Neurology. University of California San Francisco) ; Totolyan, Natalia (First Saint Petersburg State Medical University) ; Pingili, Ratnakar (Novartis Pharmaceuticals Corporation) ; Mancione, Linda (Novartis Pharmaceuticals Corporation) ; Hu, Xixi (Novartis Pharmaceuticals Corporation) ; Sullivan, Roseanne (Novartis Pharmaceuticals Corporation) ; Su, Wendy (Novartis Pharmaceuticals Corporation) ; Zielman, Ronald (Novartis Pharma B.V.) ; Gupta, Ayan Das (Novartis Healthcare Private Limited) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Winthrop, Kevin (School of Public Health at Oregon Health and Science University) ; Universitat Autònoma de Barcelona. Departament de Medicina
Introduction: The SARS-CoV-2 pandemic necessitated better understanding of the impact of disease-modifying therapies on COVID-19 outcomes and vaccination. We report characteristics of COVID-19 cases and vaccination status in ofatumumab-treated relapsing multiple sclerosis (RMS) patients. [...]
2022 - 10.1007/s40120-022-00341-z
Neurology and Therapy, Vol. 11 Núm. 2 (june 2022) , p. 741-758  
3.
4 p, 243.1 KB Correction to : COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab / Cross, Anne H. (Department of Neurology. Washington University) ; Delgado, Silvia (University of Miami Miller School of Medicine) ; Habek, Mario (University Hospital Center Zagreb. University of Zagreb. School of Medicine) ; Davydovskaya, Maria (Moscow State Public Healthcare InsCity Clinical Hospital 24) ; Ward, Brian J. (Infectious Diseases Division. Research Institute of the McGill University Health Centre) ; Cree, Bruce A. C (UCSF Weill Institute for Neurosciences. Department of Neurology. University of California San Francisco) ; Totolyan, Natalia (First Saint Petersburg State Medical University) ; Pingili, Ratnakar (Novartis Pharmaceuticals Corporation) ; Mancione, Linda (Novartis Pharmaceuticals Corporation) ; Hu, Xixi (Novartis Pharmaceuticals Corporation) ; Sullivan, Roseanne (Novartis Pharmaceuticals Corporation) ; Su, Wendy (Novartis Pharmaceuticals Corporation) ; Zielman, Ronald (Novartis Pharma B.V.) ; Gupta, Ayan Das (Novartis Healthcare Private Limited) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Winthrop, Kevin (School of Public Health at Oregon Health and Science University) ; Universitat Autònoma de Barcelona. Departament de Medicina
2022 - 10.1007/s40120-022-00346-8
Neurology and Therapy, Vol. 11 Núm. 2 (2022) , p. 759-762  

See also: similar author names
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.